Responses
Hemorrhagic Stroke
Original research
Feasibility, complications, morbidity, and mortality results at 6 months for aneurysm treatment with the Flow Re-Direction Endoluminal Device: report of SAFE study
Compose a Response to This Article
Other responses
No responses have been published for this article.